Anticardiolipin antibodies in proliferative diabetic retinopathy: An additional risk factor

Saudi Journal of Ophthalmology

Volumn 23, Issue 2, 2009, Pages 165-169

  Shahin, Maha ^a   El Diasty, Amany M ^a   Mabed, Mohamed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Anticardiolipin antibodies; Antiphospholipids antibodies; Diabetic complications; Diabetic retinopathy; Medical retina

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 72049133177     PISSN: 13194534     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjopt.2009.06.001     Document Type: Article

References (46)

1. Ahmed E., Nityanad S., Mustafa A., et al. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications. Clin. Exp. Immunol. 115 (1999) 255-259
2. Al-Abdulla N.A., Thompson J.T., and laborwit S.E. Simultaneous bilateral central retinal vein occlusion associated with anticardiolipin antibodies in leukemia. Am. J. Ophthalmol. 132 (2001) 266-268
3. Barnett A. Pathogenesis of diabetic microangiopathy: an overview. Am. J. Med. 90 (1991) 67S-73S
4. Bloodworth J.M.B. Diabetic microangiopathy. In: Bloodworth Jr. J.M.B. (Ed). Endocrine Pathology (1968), Williams and Wilkins, Baltimore 389-412
5. Bordron A., Dueymes M., Levy Y., et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J. Clin. Invest. 101 (1998) 2029-2035
6. Burkholder P.M. Immunohistopathologic study of localized plasma proteins and fixation of guinea pig complement in renal lesions of diabetic glomerulosclerosis. Diabetes 14 (1965) 755-770
7. Cabiedes J., Cabral A., and Alarcon S. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta-glycoprotein than with antiphospholipid antibodies. J. Rheumatol. 22 (1995) 1899-1906
8. Cobo-Soriano R., Sánchez-Ramón S., Aparicio M.J., et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am. J. Ophthalmol. 130 (2000) 538-539
9. Derksen R.H., and de Groot P.G. Clinical consequences of antiphospholipid antibodies. Neth. J. Med. 62 (2004) 273-278
10. Diabetic Retinopathy Study Research Group, 1981. A modification on the Airlie House classification of diabetic retinopathy. Report No. 7. Invest. Ophthalmol. Vis. Sci. 21, 210-226.
11. Diez J.J., Doforno R.A., Iglesias P., et al. Anticardiolipin antibodies in autoimmune thyroid diseases. J. Clin. Lab. Immunol. 40 (1993) 125-134
12. Elbein S.C., Hoffman M.D., Mayorga R.A., et al. Do non-insulin-dependent diabetes mellitus (NIDDM) and insulin-dependent diabetes mellitus (IDDM) share genetic susceptibility loci? An analysis of putative IDDM susceptibility regions in familial NIDDM. Metabolism 46 (1997) 48-52
13. Ermakova N.A., Alekberova Z.S., Nasonov E.L., et al. Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases. Vestn. Oftalmol. 118 (2002) 29-32
14. Foley Nalan D., Woods R., Choudhry L., et al. Anticardiolipin antibody titers in patients with myocardial infarction. Am. J. Cardiol. 68 (1991) 830-831
15. Gargiulo P., Schiaffini R., Bosco D., et al. Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type I (insulin-dependent) diabetes mellitus. Diabet. Med. 14 (1997) 132-137
16. Gargiulo P., Goldberg J., Romani B., et al. Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus. Clin. Exp. Immunol. 118 (1999) 30-34
17. Geiusti C. Are phospholipid-binding antibodies implicated in the pathogenesis of diabetic microangiopathy?. Med. Hypotheses 63 (2004) 235-238
18. Horbach D.A., van Oort E., Donders R.C., et al. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb. Haemost. 76 (1996) 916-924
19. Hughes G. Antiphospholipid syndrome: ten years on. Lancet 342 (1993) 341-344
20. Hunt J., Simpson R., and Krilis S. Identification of a region of beta-2-glycoprotein I critical for lipid binding and anticardiolipin antibody cofactor activity. Proc. Natl. Acad. Sci. USA 90 (1993) 2141-2145
21. Iverson G.M., Victoria E.J., Cockerill K.A., et al. Advances in understanding what we measure when detecting anticardiolipin autoantibodies. Clin. Chim. Acta. 343 (2004) 37-44
22. Jones D.B., Wallace R., and Frier B.M. Vascular endothelial cell antibodies in diabetic patients. Asociation with diabetic retinopathy. Diabetes Care 15 (1992) 552-555
23. Kalogeropoulos C.D., Spyrou P., Stefaninotou M.I., et al. Anticardiolipin antibodies and occlusive vascular diseases of the eye: prospective study. Doc. Ophthalmol. 95 (1998) 109-120
24. Kastelan S., Zjacić-Rotkvić V., and Kastelan Z. Could diabetic retinopathy be an autoimmune disease?. Med. Hypotheses 68 (2007) 1016-1018
25. Kato A., and Enjoji K. Amino acid sequence and location of the disulfide bonds in bovine beta 2-glycoprotein I: the presence of five such domains. Biochemistry 30 (1991) 11687-11694
26. Leske M.C., Wu S.Y., Hennis A., et al. Nine year incidence of diabetic retinopathy in the Barbados Eye studies. Arch. Ophthalmol. 124 (2006) 250-255
27. McIntyre J., and Wagenknecht D. Antiphospholipid antibodies. Risk assessments for solid organ, bone marrow, and tissue transplantation. Rheum. Dis. Clin. North Am. 27 (2001) 611-631
28. McIntyre J., Wagenknecht D., and Sugi T. Phospholipid binding plasma proteins required for antiphospholipid antibody detection. An overview. Am. J. Reprod. Immunol. 37 (1997) 101-110
29. McNeil H.P., Simpson R.J., Chesterman C.N., et al. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87 (1990) 4120-4124
30. Merkel P.A., Chang Y., Pierangeli S.S., et al. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am. J. Med. 101 (1996) 576-583
31. Michelson I. The mode of development of vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans. Ophthalmol. Soc. UK 68 (1948) 601-612
32. Mimura T., Funatsce H., Uchigata Y., et al. Development and progression of diabetic retinopathy in patients with type 1 diabetes who are positive for GAD autoantibody. Diabet. Med. 21 (2004) 559-562
33. Miserocchi E., Baltatzis S., and Foster C.S. Ocular features associated with anticardiolipin antibodies: a descriptive study. Am. J. Ophthalmol. 133 (2002) 293-294
34. Molina J.F., Gutierrez-Ureña S., Molina J., et al. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus. J. Rheumatol. 24 (1997) 291-296
35. National Diabetes Data Group. Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes 28 (1979) 1039-1057
36. Ogawa H., Zhao D., and Dlott J. Elevated anti-Annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. Am. J. Clin. Pathol. 114 (2000) 619-628
37. Passam F., and Krilis S. Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology 36 (2004) 129-138
38. Patz A. Clinical and experimental studies on retinal neovascularisation. Am. J. Ophthalmol. 94 (1982) 715-743
39. Peluso G., and Morrone G. Antiphospholipid antibodies and recurrent abortions: possible pathogenetic role of annexin A5 investigated by confocal microscopy. Minerva Ginecol. 59 (2007) 223-229
40. Schranz D., and Lemmark A. Immunology in diabetes: an update. Diabetes Metab. Res. Rev. 14 (1998) 3-29
41. Simantov R., LaSala J.M., Lo S.K., et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest. 96 (1995) 2211-2219
42. Simo R., Vidal M.T., Garcia-Arumi J., et al. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Res. Clin. Pract. 71 (2006) 36-44
43. Toschi V., Motta A., Castelli C., et al. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 29 (1998) 1759-1764
44. Vogel J., Reber G., and De Moerloose P. Laboratory and clinical features in systemic lupus erythematosus patients with or without anticardiolipin antibodies. Thromb. Res. 62 (1991) 545-556
45. Wise G. Retinal neovascularisation. Trans. Am. Ophthalmol. Soc. 54 (1956) 729-826
46. Wroblewski M., Gottsater A., Lindgarde F., et al. Gender, autoantibodies and obesity in newly diagnosed diabetic patients aged 40-75 years. Diabetes Care 21 (1998) 250-255